Cargando…

PB1778: PAN-PIM KINASE INHIBITOR PIM447 SHOWS SUPERIOR ANTI-LEUKEMIC EFFECT IN ACUTE ERYTHROID LEUKEMIA

Detalles Bibliográficos
Autores principales:	Tseng, Chi-Yang, Yu, Ya-Chu, Fu, Yu-Hsuan, Ou, Da-Liang, Lin, Liang-In
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Publication Only
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430342/ http://dx.doi.org/10.1097/01.HS9.0000973968.62100.37

Ejemplares similares

PB1814: THERAPEUTIC POTENTIAL AND STRATEGIES OF PIM447, A PAN-PIM INHIBITOR, TARGETING REFRACTORY MYELOID LEUKEMIA WITH KIT-DRIVEN T(8/21)
por: Tseng, Chi-Yang, et al.
Publicado: (2023)

Protein Translation Inhibition is Involved in the Activity of the Pan-PIM Kinase Inhibitor PIM447 in Combination with Pomalidomide-Dexamethasone in Multiple Myeloma
por: Paíno, Teresa, et al.
Publicado: (2020)

Insights into the Interaction Mechanisms of the Proviral Integration Site of Moloney Murine Leukemia Virus (Pim) Kinases with Pan-Pim Inhibitors PIM447 and AZD1208: A Molecular Dynamics Simulation and MM/GBSA Calculation Study
por: Chen, Qingqing, et al.
Publicado: (2019)

PB1794: NATURAL FLAVONOIDS INHIBIT MYELOID NEOPLASM PROLIFERATION BY REGULATING PIM2 KINASE ACTIVITY
por: Wang, Hao, et al.
Publicado: (2023)

Control of translational activation by PIM kinase in activated B-cell diffuse large B-cell lymphoma confers sensitivity to inhibition by PIM447
por: Peters, Tara L., et al.
Publicado: (2016)

PB1778: NB4 CELLS CAN SURVIVE DURING ATO TREATMENT BY REGULATING THE NUMBER OF MITOCHONDRIA
por: Ding, S., et al.
Publicado: (2022)

Loss of PIM2 enhances the anti-proliferative effect of the pan-PIM kinase inhibitor AZD1208 in non-Hodgkin lymphomas
por: Kreuz, S., et al.
Publicado: (2015)

Linac4 PIMS
por: Pantelia, Anna
Publicado: (2014)

The role of PIM1/PIM2 kinases in tumors of the male reproductive system
por: Jiménez-García, Manuel Pedro, et al.
Publicado: (2016)

Multicenter validation of PIM3 and PIM2 in Brazilian pediatric intensive care units
por: Genu, Daniel Hilário Santos, et al.
Publicado: (2022)

Protein kinase PIM2: A simple PIM family kinase with complex functions in cancer metabolism and therapeutics
por: Wang, Yixin, et al.
Publicado: (2021)

Crosslinking of Branched PIM-1 and PIM-Py Membranes for Recovery of Toluene from Dimethyl Sulfoxide by Pervaporation
por: Aloraini, Sulaiman, et al.
Publicado: (2023)

Dama de Porto Pim /
por: Tabucchi, Antonio, 1943-2012
Publicado: (1984)

El Pim-pam-pum
por: Ionesco, Eugène

Dama de Porto Pim
por: Tabucchi, Antonio 1943-
Publicado: (1997)

PIM Kinases in Multiple Myeloma
por: Wu, Jian, et al.
Publicado: (2021)

Role of PIM2 in allergic asthma
por: Du, Wei, et al.
Publicado: (2017)

PB1771: OVERCOMING RESISTANCE TO TYROSINE KINASE INHIBITORS IN MYELOID LEUKEMIA CELLS THROUGH ENHANCED FERROPTOSIS
por: Chien, Chih-Fang Chang, et al.
Publicado: (2023)

PB2258: MANAGEMENT OF FEBRILE NEUTROPENIA IN LEUKEMIC PATIENTS: A MONOCENTRIC STUDY
por: Boufrikha, W., et al.
Publicado: (2022)

PB2485: INVESTIGATING THE EXPRESSION OF MUCIN-1 (MUC-1) DURING ERYTHROID DIFFERENTIATION
por: Hassan, Hammad, et al.
Publicado: (2023)

Inflammation and stem markers association to PIM1/PIM2 kinase-induced tumors in breast and uterus
por: Jiménez-García, Manuel-Pedro, et al.
Publicado: (2017)

PB1715: UNLEASHING NATURAL KILLER (NK) CELLS TO PROMOTE ANTI-LEUKEMIC IMMUNITY
por: Tsoukala, Ioanna, et al.
Publicado: (2023)

Association between Potentially Inappropriate Medication (PIM) Use and Risk of Hospitalization in Older Adults: An Observational Study Based on Routine Data Comparing PIM Use with Use of PIM Alternatives
por: Endres, Heinz G., et al.
Publicado: (2016)

[Retracted] Expression and function of PIM kinases in osteosarcoma
por: Mou, Shuai, et al.
Publicado: (2023)

Overexpression of Pim-1 in bladder cancer
por: Guo, Shengjie, et al.
Publicado: (2010)

Targeting the Pim kinases in multiple myeloma
por: Keane, N A, et al.
Publicado: (2015)

A review on PIM kinases in tumors
por: Arrouchi, Housna, et al.
Publicado: (2019)

PIM Kinase as an Executional Target in Cancer
por: Zhang, Xinning, et al.
Publicado: (2018)

An adult presentation consistent with PIMS-TS
por: Jones, Imogen, et al.
Publicado: (2020)

Pim-selective inhibitor DHPCC-9 reveals Pim kinases as potent stimulators of cancer cell migration and invasion
por: Santio, Niina M, et al.
Publicado: (2010)

PIM1 polymorphism and PIM1 expression as predisposing factors of esophageal squamous cell carcinoma in the Asian population
por: Wu, Yuan-Bo, et al.
Publicado: (2016)

High Expression of NEK2 and PIM1, but Not PIM3, Is Linked to an Aggressive Phenotype of Bronchopulmonary Neuroendocrine Neoplasms
por: Motylewska, Ewelina, et al.
Publicado: (2020)

PB2166: PRIMARY MYELOFIBROSIS: SERUM LACTATE DEHYDROGENASE AS A PREDICTOR OF EARLY LEUKEMIC PROGRESSION
por: Moura, Pedro, et al.
Publicado: (2023)

Novel Pan-Pim Kinase Inhibitors With Imidazopyridazine and Thiazolidinedione Structure Exert Potent Antitumor Activities
por: Sawaguchi, Yuichi, et al.
Publicado: (2021)

Potentially inappropriate medications (PIMs): frequency and extent of GP-related variation in PIMs: a register-based cohort study
por: Ribe, Anette Riisgaard, et al.
Publicado: (2021)

PIM3 Promotes the Proliferation and Migration of Acute Myeloid Leukemia Cells
por: Luo, Hongmei, et al.
Publicado: (2020)

Linac4 PIMS Construction and First Operation
por: Wegner, Rolf, et al.
Publicado: (2017)

Casuïstiekprijs H&W voor Pim Keurlings
por: Smeele, Ivo
Publicado: (2021)

The Role of PIM Kinases in Pediatric Solid Tumors
por: Julson, Janet Rae, et al.
Publicado: (2022)

PIMS/MIS-C in der Omicron-Welle
por: Kerbl, Reinhold
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3eqpmkiqt6h72j48k4a2silqs8